Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
8.71 Down 0.28(3.11%) 4:00PM EDT
|After Hours : 8.65 Down 0.06 (0.69%) 7:58PM EDT
Add to Portfolio
Prev Close:8.99
Open:8.89
Bid:8.00 x 500
Ask:9.19 x 100
1y Target Est:15.50
Beta:0.220443
Next Earnings Date:N/A
Day's Range:8.63 - 9.20
52wk Range:2.31 - 14.40
Volume:2,330,585
Avg Vol (3m):3,689,400
Market Cap:1.14B
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 3.11%1.14B
IMGNDown 5.74%1.17B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):768.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Sep-15) :-0.13
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback